Navigation Links
Novel approach scores first success against elusive cancer gene
Date:9/9/2011

Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's "on" switch and growth signals, rather than targeting the gene itself. The results, achieved in multiple myeloma cells, offer a promising strategy for treating not only myeloma but also many other cancer types driven by the gene MYC, the study authors say. Their findings are being published by the journal Cell on its website Sept. 1 and in its Sept. 16 print edition.

"Cancer is a disease of disregulation of growth genes in a cell, and MYC is a master regulator of these genes," says James E. Bradner, MD, of Dana-Farber, one of the study's senior authors. Previous attempts to shut down MYC by inhibiting it directly with drug molecules have been notably unsuccessful. "In this study, our idea was to switch MYC off, interfering with its ability to activate the cell-growth program."

They did so with a small molecule called JQ1, developed by Dana-Farber's Jun Qi, PhD, a co-author of the new study and namesake of JQ1. In multiple myeloma, MYC is hyperactive constantly ordering cells to grow and divide because it is in the wrong position in the cells' chromosomes. Instead of its normal, quiet neighborhood, MYC finds itself adjacent to a gene known as the immunoglobulin gene. This busy gene is switched on by bits of DNA known as immunoglobulin enhancers, which normally prompt the cell to begin producing disease-fighting antibodies. In myeloma, the immunoglobulin enhancers act on the out-of-place MYC gene like an impatient finger at a doorbell, repeatedly activating it.

Researchers found that the enhancers are loaded with a "bromodomain" protein called BRD4, which, they demonstrate, is used to switch on MYC. Conveniently, it is targeted by JQ1. When investigators added JQ1 to laboratory samples of myeloma cells, the bromodomain proteins fell off the enhancers and th
'/>"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Novel method for increasing antibiotic yields
2. Tropical coral could be used to create novel sunscreens for human use, say scientists
3. A novel mechanism that regulates pro-inflammatory cells is identified
4. Novel analysis by Allen Institute sheds new light on the mechanisms of brain development
5. Novel gene increases yeasts appetite for plant sugars
6. Life scientists use novel technique to produce genetic map for African Americans
7. Parkinsons Disease Foundation announces $1 million for novel studies into Parkinsons
8. UTHealth awarded FEMA grant to explore novel obesity risk factor among firefighters
9. Efficiency record for flexible CdTe solar cell due to novel polyimide film
10. New clinical trial to test novel approach to treat triple-negative breast cancer
11. Novel prodrug alleviates symptoms in Huntingtons and Alzheimers mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2015)... , June 17, 2015  Crossmatch™, a leading ... that its U.are.U ® 4500 fingerprint readers ... Eateries, Inc., a San Jose, ... to increase security, improve accountability and reduce fraud ... instant, non-repudiable identity confirmation for employee sign in ...
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... including all touch fingerprint sensors in the company,s portfolio from ... . Deliveries are planned to mainly take place during the ... manufacturers in Asia . Jörgen ... another evidence of    the   growing interest from smartphone ...
(Date:6/15/2015)... YORK , June 15, 2015 ... today from Telstra reveals the majority of US consumers using ... them via biometrics, such as fingerprint and voiceprint, instead of ... According to Telstra,s " Mobile Identity   - ... " report, with smartphones now the primary channel used ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... Large college athletics departments talk the talk ... and environmental sustainability, but only a small percentage ... making their operations "greener." It turns out ... other campus departments charged with advancing environmental sustainability, ...
... February, 2012The World Economic Forum,s Global Agenda Council on ... Technologies" that will change the world in the years ... impact on the state of the world in the ... of experts from science, businesses, and public policy. The ...
... Feb. 14, 2012, Cleveland: In an effort to study ... has joined the ongoing efforts of 23andMe, a leading ... in research by contributing their DNA to a research ... Currently, little is known about how genes relate ...
Cached Biology News:Sustainability, college athletics don't always connect 2Important Emerging Technologies for the 21st Century 2Important Emerging Technologies for the 21st Century 3Cleveland Clinic joins 23andMe in the search for genetic clues to Parkinson's disease 2Cleveland Clinic joins 23andMe in the search for genetic clues to Parkinson's disease 3
(Date:6/29/2015)... Ga. , June 29, 2015  MiMedx Group, ... company utilizing human amniotic tissue and patent-protected processes to ... Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... CEO, Parker H. "Pete" Petit, has been awarded the ... Year® 2015 Southeast Program. The Entrepreneur ...
(Date:6/29/2015)... 29, 2015 According to a new ... by Application (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), ... CRO) - Global Forecast to 2020", published by MarketsandMarkets, the ... 2020 from $107.56 Million in 2015, at a CAGR of ... and 67 F igures spread through 125 ...
(Date:6/29/2015)... FRANCISCO, Calif. , June 29, 2015   ... diagnostics company pioneering the field of molecular cytology, today ... Area News Group,s prestigious Top Workplaces list for the ... Top Workplace winners based solely on an annual survey ... humbled and honored that the degree to which Veracyte ...
(Date:6/29/2015)... , June 29, 2015 ... medical information products and services, today announced the highlights ... to the 2014 Journal Citation Reports® (JCR) published by ... Factors increase from 2013 to 2014, ahead of the ... the top rank in 62 subject categories, up from ...
Breaking Biology Technology:EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2Aptamers Market Worth $244.93 Million by 2020 2Aptamers Market Worth $244.93 Million by 2020 3Aptamers Market Worth $244.93 Million by 2020 4Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3
... HUNTINGTON BEACH, California and AMSTERDAM, The Netherlands, February ... diagnostics,today announced the appointment of Alan B. Carter ... Development. , "As we ... appointment furthers,one of our primary aims," commented Dr. ...
... Feb. 11 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ("China ... markets specialty pharmaceutical products in China,announced today that ... generic,version of the leading hypertension drug Candesartan. , ... this product are anticipated to require,approximately 18 months ...
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), a ... novel drugs in the therapeutic,areas of infection, cancer and ... quarter and full year ended December 31,2008. , ... The net loss allocable to ...
Cached Biology Technology:Agendia Appoints VP of Business Development 2China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan 2China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan 3Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 2Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 3Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 4Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 5Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 6Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 7Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 8Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 9Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 10Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 11Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results 12